Clinical trial
A Randomized Controlled Trial of Adjunctive Tocilizumab in Schizophrenia
NCT02874573 is registered in ClinicalTrials.gov with Brian Miller as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Trial of Adjunctive Tocilizumab in Schizophrenia
- Lead sponsor
- Brian Miller
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- September 30, 2016
- Completion date
- December 31, 2023
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.